Vir Biotechnology (VIR) Depreciation & Amortization (CF) (2018 - 2026)

Vir Biotechnology's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 1.95% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $11.6 million (down 9.95% YoY), while the FY2025 annual figure was $11.7 million, down 19.77% from the prior year.
• Depreciation & Amortization (CF) came in at $2.8 million for Q1 2026 at Vir Biotechnology, down from $2.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.6 million in Q1 2023 to a low of $1.4 million in Q1 2022.
• A 5-year average of $3.2 million and a median of $2.9 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) jumped 297.32% in 2023 and plunged 36.53% in 2025, its largest moves.
• Vir Biotechnology's Depreciation & Amortization (CF) stood at $2.4 million in 2022, then soared by 90.43% to $4.5 million in 2023, then plunged by 35.57% to $2.9 million in 2024, then advanced by 0.42% to $2.9 million in 2025, then decreased by 3.0% to $2.8 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $2.8 million, $2.9 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison